MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Levodopa(L-dopa)"

  • 2019 International Congress

    The effect of ADORA2A gene polymorphism on the dyskinesia of Parkinson’s Disease

    BC. Ari, F. Mayda Domac, G. Ozgen Kenangil, N. Imamova, A. Cinar Kuskucu (Istanbul, Turkey)

    Objective: To investigate the relationship of levodopa-induced dyskinesia with ADORA2A gene polymorphisms in PD patients. Background: With the progression of the disease, motor complications and…
  • 2019 International Congress

    Memory enhancing effect of Combined Alcoholic Extract of Cedrus deodara Loud. and Vitex Nirgundi in scopolamine-induced cognitive impairment in mice

    A. Jain, S. Jain (Sagar, India)

    Objective: Epidemiological studies of Indian population reveal that dementia is largely a hidden problem in India. Ayurveda claims several plants are beneficial in cognitive disorders.…
  • 2019 International Congress

    Effects of levodopa on prosaccade performance and visual target eccentricity

    A. Yugeta, Y. Terao, Y. Ugawa (Tokyo, Japan)

    Objective: To investigate whether the effect of levodopa on saccade is the same to visual targets of small and large eccentricities in Parkinson’s disease (PD)…
  • 2019 International Congress

    Preserved white matter microstructure in Parkinson’s disease patients with levodopa-induced dyskinesia: Evaluation by neurite orientation dispersion and density imaging (NODDI)

    T. Ogawa, T. Hatano, H. Takeshige, C. Andica, K. Kamagata, A. Saito, T. Koinuma, R. Nakamura, H. Iwamuro, G. Oyama, Y. Shimo, A. Umemura, M. Ito, S. Aoki, N. Hattori (Tokyo, Japan)

    Objective: Brain microstructure alteration using MRI in Parkinson's disease (PD) have not been well studied. We analysis the white matter alterations in Parkinson’s disease with…
  • 2019 International Congress

    Impulse control and repetitive behavior disorders are more common in PD patients with levodopa-induced dyskinesias

    F. Paolini Paoletti, N. Tambasco, G. Cappelletti, P. Eusebi, S. Simoni, P. Nigro, E. Brahimi, M. Filidei, P. Calabresi (Perugia, Italy)

    Objective: Our aim was to evaluate the prevalence of impulse control and repetitive behavior disorders (ICRB) in patients affected by Parkinson's disease (PD) with and without levodopa-induced…
  • 2019 International Congress

    Evaluating the real-world effectiveness of carbidopa/levodopa enteral suspension (CLES) on patients with advanced Parkinson’s disease in USA: Interim-evidence from the PROviDE study

    R. Pahwa, S. Isaacson, P. Kandukuri, Y. Jalundhwala, P. Kukreja, Y. Bao, N. Gupta, I. Pan, J. Aldred (Kansas City, KS, USA)

    Objective: To evaluate the real-world effectiveness of carbidopa/levodopa enteral suspension (CLES) in patients with advanced Parkinson’s disease (PD) in real world at home setting in…
  • 2019 International Congress

    Changes in close relationships among patients with Parkinson’s disease and their partners following initiation of device-aided treatment

    J. Timpka, M. Scharfenort, T. Sahlström, V. Hernström, T. Henriksen, D. Nyholm, P. Odin (Lund, Sweden)

    Objective: Our primary objective was to study whether there is a difference in how close relationships are perceived by Parkinson’s disease (PD) patients with device-aided…
  • 2019 International Congress

    Patients Experiencing Motor Fluctuations With Parkinson’s Disease (PD): Participant Characteristics in the Accordance Phase 3 Efficacy and Safety Trial of Accordion Pill™ Carbidopa/Levodopa

    P. Lewitt, R. Gendreau, J. Meckler, A. Hotovely-Salomon, N. Navon (West Bloomfield, MI, USA)

    Objective: To provide baseline and clinical characteristics for participants in the phase 3 Accordance study of the Accordion Pill™ (AP)—a gastric-retentive formulation of carbidopa/levodopa (CD/LD)—versus…
  • 2019 International Congress

    Toning down SPNs to improve motor responses to dopaminergic stimulation in Parkinson’s disease

    G. Beck, H. Mochizuki, S. Papa (Atlanta, GA, USA)

    Objective: This study was aimed at examining whether decreasing the baseline SPN firing frequency towards the low activity found in normal conditions reduces LID. Background:…
  • 2019 International Congress

    Are there associations between altered brain connectivity and dopaminergic medication in Parkinson’s disease patients with freezing of gait?

    A. Potvin-Desrochers, A. Atri, C. Paquette (Montreal, QC, Canada)

    Objective: The purpose of this study is to assess how brain connectivity is altered in Parkinson’s disease (PD) patients with freezing of gait (FOG), and…
  • « Previous Page
  • 1
  • …
  • 35
  • 36
  • 37
  • 38
  • 39
  • …
  • 62
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley